
Katherine Hamilton
Real-Time News Reporter at The Wall Street Journal
Personal finance reporter @WSJ | Previous work in @VirginiaBiz, @Forbes, @CoStarNews and @WBJournal
Articles
-
1 week ago |
wsj.com | Katherine Hamilton
May 5, 2025 9:09 am ETSkechers agreed to become a privately held company through a merger with 3G Capital. Skechers SKX 3.44 %increase; green up pointing triangle agreed to become a privately held company through a merger with 3G Capital. The footwear company said Monday 3G plans to pay $63 a share in cash for all of Skechers’s outstanding shares.
-
1 week ago |
wsj.com | Katherine Hamilton
The decision came after 20% of the FAA controllers at Newark walked off the job, CEO Scott Kirby saidUnited Airlines is cancelling 35 daily round trip flights from Newark, N.J., starting this weekend after a group of air-traffic controllers walked off the job. Chief Executive Scott Kirby said Friday the decision came after 20% of the Federal Aviation Administration controllers at Newark Liberty International Airport walked off the job.
-
1 week ago |
wsj.com | Katherine Hamilton
The candy maker posted a profit of $224.2 millionHershey first-quarter earnings fell and the company expects to take a hit from tariffs of up to $20 million this quarter. The candy maker on Thursday posted a profit of $224.2 million, or $1.10 a share, in the quarter ended March 31, compared with $797.5 million, or $3.89 a share, a year earlier. Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8Subscribe NowAlready a subscriber? Sign In
-
2 weeks ago |
wsj.com | Katherine Hamilton
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed byour Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contactDow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/business/deals/novartis-to-acquire-regulus-in-1-7-billion-deal-6701a037
-
2 weeks ago |
in.marketscreener.com | Katherine Hamilton
By Katherine Hamilton Novartis has agreed to acquire Regulus Therapeutics for a total equity value of up to roughly $1.7 billion. With the merger, the Swiss pharmaceutical company aims to bring to more patients farabursen, a kidney-disease treatment developed by Regulus, the companies said Wednesday. Shares of Regulus, a San Diego biopharmaceutical company specializing in medicines targeting microRNAs, rocketed 135% to $7.90 in premarket trading Wednesday.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 167
- Tweets
- 28
- DMs Open
- Yes

RT @WSJ: When a star couple of social media splits, how do you value their biggest asset—followers—and divvy them up? Inside the murky math…

RT @WSJ: Republicans in 2017 passed a cap on the SALT deduction, limiting a big tax break for homeowners in high-cost states. Donald Trump…

RT @WSJ: The two candidates for vice president have little in common politically or financially. Here's how the rival running mates manage…